Remdesivir Completed Phase 3 Trials for Coronavirus Disease 2019 (COVID‑19) Treatment

Back to Remdesivir
IndicationsStatusPurposePhase
CompletedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04401579Adaptive COVID-19 Treatment Trial 2 (ACTT-2)
NCT04853901Remdesivir Efficacy In Management Of COVID-19 Patients
NCT04292730Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment
NCT04492475Adaptive COVID-19 Treatment Trial 3 (ACTT-3)
NCT04292899Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)
NCT04280705Adaptive COVID-19 Treatment Trial (ACTT)